Position in CMPX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,513,768
-$1,217,599 QoQ
Shares Held
15,219,994
0.0% QoQ
Ownership
8.45%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CMPX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. CMPX ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
This page
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,475,403 | $71,114,424 |
All Filings in CMPX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,513,768 | 15,219,994 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,731,367 | 15,219,994 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $53,269,979 | 15,219,994 | Shares | Sole | 2025-11-14 | |
| 2025-08-13 | $47,181,981 | 15,219,994 | Shares | Sole | 2025-08-15 | |
| 2025-06-30 | $39,571,984 | 15,219,994 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,489,415 | 22,362,850 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $32,426,132 | 22,362,850 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,147,644 | 22,362,850 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,362,850 | 22,362,850 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $44,278,443 | 22,362,850 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $34,886,046 | 22,362,850 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $44,054,814 | 22,362,850 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $71,113,863 | 22,362,850 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,126,519 | 22,362,850 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $112,485,135 | 22,362,850 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $50,070,738 | 21,960,850 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $58,196,252 | 21,960,850 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $29,650,875 | 21,642,975 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $68,608,230 | 21,642,975 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||